From Discovery to IND Special Session  |  11:30 am - 12:30 pm ET

Session Chairs:
Dongmei Wang,Executive Vice President, Frontage Laboratories
Yi Zhu, Vice President, Head of Global Clinical Development, Ionova Life Science

Speakers:
Dongmei Wang, Executive Vice President, Frontage Laboratories
- Program introduction and Preclinical Development

Mingshe Zhu, Independent consultant and DMPK Scientific Advisor of BioDuro
- Modality-Driven ADME Strategies to Enable Discovery and IND Success

Yi Zhu, Vice President & Head of Global Clinical Development, Ionova Life Science
- Develop early clinical pathways and aligning programs with scientific hypotheses and Business Plans

Daniel Zhu, Senior Director of Clinical Development, BioNTech
- Real-world experience in protocol design, patient recruitment, and dose escalation

Qi Xia, Director of Biostatistics, Geron Corporation; Adjunct Professor, Loyola University
- Statistical Design and Decision-Making in Early Drug Development

Audrey Jia, Former FDA reviewer, Founder of Wonderfulland
- Regulatory perspective for successful filing to FDA

Jerry Liu, Partner, Fox Rothschild
- Key Legal Considerations for Professors When Establishing a Company

Vivian Li, Early-Stage Investor, K2VC
- From Paper to Pitch Deck: What Makes Academic Research Investable?

Please note there is a cost to attend.